Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 9/2014

01-09-2014 | Article

Emerging Trichosporon asahii in elderly patients: epidemiological and molecular analysis by the DiversiLab system

Authors: M. Treviño, C. García-Riestra, P. Areses, X. García, D. Navarro, F. J. Suárez, I. A. López-Dequidt, O. Zaragoza, M. Cuenca-Estrella

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 9/2014

Login to get access

Abstract

Trichosporon asahii has been recognized as an emerging opportunistic agent for invasive infections, mainly in immunocompromised patients. Urinary tract infections by this pathogen may also occur, especially in patients with urinary obstruction or those undergoing vesical catheterization and antibiotic treatment. Many outbreaks of Trichosporon spp. have been detected after urinary catheter manipulations. We report the molecular–epidemiological characterization of T. asahii in our institution using the DiversiLab system for the molecular strain typing and compare three different methods for susceptibility testing. Our results present T. asahii as an emergent pathogen in elderly patients with urinary drainage devices that can be adequately treated with triazoles, with voriconazole being the most active. Broth dilution and Vitek 2 had good concordance, while Etest showed more discrepancies. In addition, the DiversiLab system for clonal strain typing may be a useful tool for fast and accurate management of nosocomial outbreaks.
Literature
1.
go back to reference Chagas-Neto TC, Chaves GM, Colombo AL (2008) Update on the genus Trichosporon. Mycopathologia 166:121–132PubMedCrossRef Chagas-Neto TC, Chaves GM, Colombo AL (2008) Update on the genus Trichosporon. Mycopathologia 166:121–132PubMedCrossRef
3.
go back to reference Kontoyannis DP, Torrs HA, Chagua M et al (2004) Trichosporonosis in a tertiary care cancer center: risk factors, changing spectrum and determinants of outcome. Scand J Infect Dis 36:564–569CrossRef Kontoyannis DP, Torrs HA, Chagua M et al (2004) Trichosporonosis in a tertiary care cancer center: risk factors, changing spectrum and determinants of outcome. Scand J Infect Dis 36:564–569CrossRef
4.
go back to reference Krzossok S, Birck R, Henke S, Hof H, van der Woude FJ, Braun C (2004) Trichosporon asahii infection of a dialysis PTFE arteriovenous graft. Clin Nephrol 62:66–68PubMedCrossRef Krzossok S, Birck R, Henke S, Hof H, van der Woude FJ, Braun C (2004) Trichosporon asahii infection of a dialysis PTFE arteriovenous graft. Clin Nephrol 62:66–68PubMedCrossRef
5.
go back to reference Falk R, Wolf DG, Shapiro M, Polacheck I (2003) Multidrug-resistant Trichosporon asahii isolates are susceptible to voriconazole. J Clin Microbiol 41:911PubMedCentralPubMedCrossRef Falk R, Wolf DG, Shapiro M, Polacheck I (2003) Multidrug-resistant Trichosporon asahii isolates are susceptible to voriconazole. J Clin Microbiol 41:911PubMedCentralPubMedCrossRef
6.
go back to reference Sun W, Su J, Xu S, Yan D (2012) Trichosporon asahii causing nosocomial urinary tract infections in intensive care unit patients: genotypes, virulence factors and antifungal susceptibility testing. J Med Microbiol 61:1750–1757PubMedCrossRef Sun W, Su J, Xu S, Yan D (2012) Trichosporon asahii causing nosocomial urinary tract infections in intensive care unit patients: genotypes, virulence factors and antifungal susceptibility testing. J Med Microbiol 61:1750–1757PubMedCrossRef
7.
go back to reference Rodriguez-Tudela JL, Diaz-Guerra TM, Mellado E et al (2005) Susceptibility patterns and molecular identification of Trichosporon species. Antimicrob Agents Chemother 49:4026–4034PubMedCentralPubMedCrossRef Rodriguez-Tudela JL, Diaz-Guerra TM, Mellado E et al (2005) Susceptibility patterns and molecular identification of Trichosporon species. Antimicrob Agents Chemother 49:4026–4034PubMedCentralPubMedCrossRef
8.
go back to reference Subcommittee on Antifungal Susceptibility Testing (AFST) of the ESCMID European Committee for Antimicrobial Susceptibility Testing (EUCAST) (2008) EUCAST definitive document EDef 7.1: method for the determination of broth dilution MICs of antifungal agents for fermentative yeasts. Clin Microbiol Infect 14:398–405CrossRef Subcommittee on Antifungal Susceptibility Testing (AFST) of the ESCMID European Committee for Antimicrobial Susceptibility Testing (EUCAST) (2008) EUCAST definitive document EDef 7.1: method for the determination of broth dilution MICs of antifungal agents for fermentative yeasts. Clin Microbiol Infect 14:398–405CrossRef
10.
go back to reference Sugita T, Nakajima M, Ikeda R, Matsushima T, Shinoda T (2002) Sequence analysis of the ribosomal DNA intergenic spacer 1 regions of Trichosporon species. J Clin Microbiol 40:1826–1830PubMedCentralPubMedCrossRef Sugita T, Nakajima M, Ikeda R, Matsushima T, Shinoda T (2002) Sequence analysis of the ribosomal DNA intergenic spacer 1 regions of Trichosporon species. J Clin Microbiol 40:1826–1830PubMedCentralPubMedCrossRef
11.
go back to reference Rodriguez-Tudela JL, Gómez-López A, Alastruey-Izquierdo A, Mellado E, Bernal-Martínez L, Cuenca-Estrella M (2007) Genotype distribution of clinical isolates of Trichosporon asahii based on sequencing of intergenic spacer 1. Diagn Microbiol Infect Dis 58:435–440PubMedCrossRef Rodriguez-Tudela JL, Gómez-López A, Alastruey-Izquierdo A, Mellado E, Bernal-Martínez L, Cuenca-Estrella M (2007) Genotype distribution of clinical isolates of Trichosporon asahii based on sequencing of intergenic spacer 1. Diagn Microbiol Infect Dis 58:435–440PubMedCrossRef
12.
go back to reference Rodrigues Gda S, de Faria RR, Guazzelli LS, Oliveira Fde M, Severo LC (2006) Nosocomial infection due to Trichosporon asahii: clinical revision of 22 cases. Rev Iberoam Micol 23:85–89PubMedCrossRef Rodrigues Gda S, de Faria RR, Guazzelli LS, Oliveira Fde M, Severo LC (2006) Nosocomial infection due to Trichosporon asahii: clinical revision of 22 cases. Rev Iberoam Micol 23:85–89PubMedCrossRef
13.
go back to reference Li H, Lu Q, Wan Z, Zhang J (2010) In vitro combined activity of amphotericin B, caspofungin and voriconazole against clinical isolates of Trichosporon asahii. Int J Antimicrob Agents 35:550–552PubMedCrossRef Li H, Lu Q, Wan Z, Zhang J (2010) In vitro combined activity of amphotericin B, caspofungin and voriconazole against clinical isolates of Trichosporon asahii. Int J Antimicrob Agents 35:550–552PubMedCrossRef
14.
go back to reference Hazirolan G, Cantón E, Sahin S, Arikan-Akdagli S (2013) Head-to-head comparison of inhibitory and fungicidal activities of fluconazole, itraconazole, voriconazole, posaconazole, and isavuconazole against clinical isolates of Trichosporon asahii. Antimicrob Agents Chemother 57:4841–4847PubMedCentralPubMedCrossRef Hazirolan G, Cantón E, Sahin S, Arikan-Akdagli S (2013) Head-to-head comparison of inhibitory and fungicidal activities of fluconazole, itraconazole, voriconazole, posaconazole, and isavuconazole against clinical isolates of Trichosporon asahii. Antimicrob Agents Chemother 57:4841–4847PubMedCentralPubMedCrossRef
15.
go back to reference Mekha N, Sugita T, Ikeda R et al (2010) Genotyping and antifungal drug susceptibility of the pathogenic yeast Trichosporon asahii isolated from Thai patients. Mycopathologia 169:67–70PubMedCrossRef Mekha N, Sugita T, Ikeda R et al (2010) Genotyping and antifungal drug susceptibility of the pathogenic yeast Trichosporon asahii isolated from Thai patients. Mycopathologia 169:67–70PubMedCrossRef
16.
go back to reference Tsai MS, Yang YL, Wang AH et al (2012) Susceptibilities to amphotericin B, fluconazole and voriconazole of Trichosporon clinical isolates. Mycopathologia 174:121–130PubMedCrossRef Tsai MS, Yang YL, Wang AH et al (2012) Susceptibilities to amphotericin B, fluconazole and voriconazole of Trichosporon clinical isolates. Mycopathologia 174:121–130PubMedCrossRef
17.
go back to reference Ruan SY, Chien JY, Hsueh PR (2009) Invasive trichosporonosis caused by Trichosporon asahii and other unusual Trichosporon species at a medical center in Taiwan. Clin Infect Dis 49:e11–e17PubMedCrossRef Ruan SY, Chien JY, Hsueh PR (2009) Invasive trichosporonosis caused by Trichosporon asahii and other unusual Trichosporon species at a medical center in Taiwan. Clin Infect Dis 49:e11–e17PubMedCrossRef
18.
go back to reference Silva V, Zepeda G (2003) First Chilean report of nosocomial urinary tract infection due to Trichosporon asahii in 2 patients. Rev Med Chil 131:461–463PubMed Silva V, Zepeda G (2003) First Chilean report of nosocomial urinary tract infection due to Trichosporon asahii in 2 patients. Rev Med Chil 131:461–463PubMed
19.
go back to reference Walsh TJ, Melcher GP, Rinaldi MG et al (1990) Trichosporon beigelii, an emerging pathogen resistant to amphotericin B. J Clin Microbiol 28:1616–1622PubMedCentralPubMed Walsh TJ, Melcher GP, Rinaldi MG et al (1990) Trichosporon beigelii, an emerging pathogen resistant to amphotericin B. J Clin Microbiol 28:1616–1622PubMedCentralPubMed
20.
go back to reference Cejudo MA, Gallego AG, Lacasa EC et al (2010) Evaluation of the VITEK 2 system to test the susceptibility of Candida spp., Trichosporon asahii and Cryptococcus neoformans to amphotericin B, flucytosine, fluconazole and voriconazole: a comparison with the M27-A3 reference method. Med Mycol 48:710–719PubMedCrossRef Cejudo MA, Gallego AG, Lacasa EC et al (2010) Evaluation of the VITEK 2 system to test the susceptibility of Candida spp., Trichosporon asahii and Cryptococcus neoformans to amphotericin B, flucytosine, fluconazole and voriconazole: a comparison with the M27-A3 reference method. Med Mycol 48:710–719PubMedCrossRef
21.
go back to reference Lemes RM, Lyon JP, Moreira LM, de Resende MA (2010) Antifungal susceptibility profile of Trichosporon isolates: correlation between CLSI and etest methodologies. Braz J Microbiol 41:310–315PubMedCentralPubMedCrossRef Lemes RM, Lyon JP, Moreira LM, de Resende MA (2010) Antifungal susceptibility profile of Trichosporon isolates: correlation between CLSI and etest methodologies. Braz J Microbiol 41:310–315PubMedCentralPubMedCrossRef
22.
go back to reference Healy M, Reece K, Walton D et al (2005) Use of the Diversi Lab System for species and strain differentiation of Fusarium species isolates. J Clin Microbiol 43:5278–5280PubMedCentralPubMedCrossRef Healy M, Reece K, Walton D et al (2005) Use of the Diversi Lab System for species and strain differentiation of Fusarium species isolates. J Clin Microbiol 43:5278–5280PubMedCentralPubMedCrossRef
23.
go back to reference Pounder JI, Williams S, Hansen D, Healy M, Reece K, Woods GL (2005) Repetitive-sequence-PCR-based DNA fingerprinting using the Diversilab system for identification of commonly encountered dermatophytes. J Clin Microbiol 43:2141–2147PubMedCentralPubMedCrossRef Pounder JI, Williams S, Hansen D, Healy M, Reece K, Woods GL (2005) Repetitive-sequence-PCR-based DNA fingerprinting using the Diversilab system for identification of commonly encountered dermatophytes. J Clin Microbiol 43:2141–2147PubMedCentralPubMedCrossRef
24.
go back to reference Cangelosi GA, Freeman RJ, Lewis KN et al (2004) Evaluation of a high-throughput repetitive-sequence-based PCR system for DNA fingerprinting of Mycobacterium tuberculosis and Mycobacterium avium complex strains. J Clin Microbiol 42:2685–2693PubMedCentralPubMedCrossRef Cangelosi GA, Freeman RJ, Lewis KN et al (2004) Evaluation of a high-throughput repetitive-sequence-based PCR system for DNA fingerprinting of Mycobacterium tuberculosis and Mycobacterium avium complex strains. J Clin Microbiol 42:2685–2693PubMedCentralPubMedCrossRef
25.
go back to reference Healy M, Reece K, Walton D, Huong J, Shah K, Kontoyiannis DP (2004) Identification to the species level and differentiation between strains of Aspergillus clinical isolates by automated repetitive-sequence-based PCR. J Clin Microbiol 42:4016–4024PubMedCentralPubMedCrossRef Healy M, Reece K, Walton D, Huong J, Shah K, Kontoyiannis DP (2004) Identification to the species level and differentiation between strains of Aspergillus clinical isolates by automated repetitive-sequence-based PCR. J Clin Microbiol 42:4016–4024PubMedCentralPubMedCrossRef
26.
go back to reference Kontoyiannis DP, Lionakis MS, Lewis RE et al (2005) Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case–control observational study of 27 recent cases. J Infect Dis 191:1350–1360PubMedCrossRef Kontoyiannis DP, Lionakis MS, Lewis RE et al (2005) Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case–control observational study of 27 recent cases. J Infect Dis 191:1350–1360PubMedCrossRef
27.
go back to reference Redkar RJ, Dubé MP, McCleskey FK, Rinaldi MG, Del Vecchio VG (1996) DNA fingerprinting of Candida rugosa via repetitive sequence-based PCR. J Clin Microbiol 34:1677–1681PubMedCentralPubMed Redkar RJ, Dubé MP, McCleskey FK, Rinaldi MG, Del Vecchio VG (1996) DNA fingerprinting of Candida rugosa via repetitive sequence-based PCR. J Clin Microbiol 34:1677–1681PubMedCentralPubMed
Metadata
Title
Emerging Trichosporon asahii in elderly patients: epidemiological and molecular analysis by the DiversiLab system
Authors
M. Treviño
C. García-Riestra
P. Areses
X. García
D. Navarro
F. J. Suárez
I. A. López-Dequidt
O. Zaragoza
M. Cuenca-Estrella
Publication date
01-09-2014
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 9/2014
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-014-2099-6

Other articles of this Issue 9/2014

European Journal of Clinical Microbiology & Infectious Diseases 9/2014 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.